SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.
IP-Watch Briefs

Inside Views

Contribute your views! Submit an Inside Views idea to info [at] ip-watch [dot] ch.

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

Call For Transparency In The Trans-Pacific Partnership Negotiation

In this post, three US law professors explain a recent call by over 30 legal scholars for the US Trade Representative to increase transparency for the Trans-Pacific Partnership Agreement intellectual property chapter, and their response to Ambassador Kirk’s response that he is “strongly offended” by the suggestion that the negotiation is not adequately transparent already.





Latest Comments
  • David, thank you for the note. It appears there is... »
  • The link to the US proposal seems to be broken, an... »

  • For IPW Subscribers
    A guide to Geneva-based public health and intellectual property organisations. Read More >

    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >


    World Health Assembly Finds Way Forward On Pandemic Flu

    Published on 22 May 2009 @ 3:44 pm

    By , Intellectual Property Watch

    Responsibility to take forward a still in-progress framework to cope with global influenza pandemics is now in the hands of the World Health Organization Director General Margaret Chan, member states agreed in a meeting Thursday. This was approved by the full World Health Assembly on Friday.

    Chan will “facilitate a transparent process to finalise the remaining elements” of the agreement and report the work to the next meeting of the WHO Executive Board in January.

    The framework is intended to set forth guidelines for the sharing of viruses, vaccines, and other benefits related to pandemic strains of influenza. This includes mechanisms for tracing and reporting outbreaks, as well as for capacity building, technology transfer, and stockpiles of vaccines. It also includes a model binding contract for entities sharing viruses with pandemic potential.

    After working for the last two years to bridge differences over what guidelines are needed to ensure the readiness of the world, and especially its poorest places, to cope with a potential global pandemic, member states proved unable to find consensus on several key parts of the framework, in particular a standard material transfer agreement (SMTA), a legally-binding document to be used in the case of virus sharing.

    The Intergovernmental Meeting (IGM) on Pandemic Influenza Preparedness concluded its final meeting on Saturday (IPW, WHO, 18 May 2009).

    Member states came to the 18-22 May World Health Assembly (WHA) with the incomplete body of work and the conviction that “the half-finished work of IGM can’t be left as it is,” as India said during the WHA.

    “Development of a fair and equitable system is vital to continuing pandemic influenza preparedness efforts, [and] trust in the previous system has broken down,” said the Australian delegation, during the Thursday meeting. It is “most important to finish the SMTA,” they added.

    Process Concerns

    The biggest concern was over what kind of process the way forward would entail.

    Some wanted more formalised negotiations, believing the legitimacy of a multilateral, process including all member states was necessary to lend appropriate weight to the remaining text, which many consider to contain the most critical elements of the framework. Without a formal process, they were concerned that unfinished parts of the text would never be fully addressed.

    “Collective good from international regimes gain strength and legitimacy when they come from member-driven negotiation,” said Brazil during the meeting.

    Others were concerned that formal consultations would be a repeat of the IGM process, which over the last two years had failed to produce an agreement. Formal talks, they said, are expensive, have not proven effective, and would keep health ministers away from their countries precisely when they are needed most: while the threat of a pandemic outbreak looms.

    The “more we think of it, the less we see a reason to create another IGM that would be redundant at this time,” Israel said during the Thursday meeting.

    One nation, Thailand, was frustrated enough with the process that they even suggested terminating the discussion. If there is good public spirit, the delegation said during the meeting, much can be achieved without resolution. Further, they did not want a resolution that would be “just another pile of papers to help lawyers make their livings.” But, they said they would accept a resolution on a way forward to please other delegations.

    Israel agreed, saying that the process for dealing with pandemic influenza needed to “be result and not resolution oriented,” but also said that they could accept a way forward.

    In the end, careful language was found to bridge the gap. It reads that member states:

    “Request the director general to facilitate a transparent process to finalise the remaining elements, including the standard material transfer agreement and its annex, and report the outcome to the Executive Board at its 126th session in January 2010.”

    The use of the word ‘finalise,’ said Chan in the meeting, is important because it emphasises that member states want results. Notably excluded from the text is the word “negotiations,” which Chan said is a term of art meaning another intergovernmental meeting.

    Also excised from the text was “all member states,” which caused concern from developing and least developed country members who were worried their voices would not be heard. But Chan said it was for pragmatic purposes, and promised in her meetings she would choose a geographically and gender balanced group.

    The resolution also asks the director general to take forward elements of the framework on which there is already consensus. These include key agreements on benefit-sharing and aspects of virus-sharing.

    Reactions As Governments Look Forward

    “Now it’s anchored,” said Abdulsalami Nasidi of Nigeria, who had drafted part of an original proposal on a way forward and who had chaired one of the working groups during the IGM process (IPW, WHO, 19 May 2009). “Now I can be proud to be part of the IGM; it’s a beautiful end.”

    Part of the reason for the successful way forward, he told Intellectual Property Watch, was the willingness of the United States and Mexico to share viruses and science during the H1N1 swine flu outbreak, “to the surprise of many.”

    Now it is just necessary to facilitate a process of sharing outside of an emergency situation, “because emergencies happen without warning.”

    However, states “have to be careful” during the process, said Silvio Albuquerque from the Brazilian delegation. Brazil was a leading voice in calling for a more formal way forward.

    “We trust the director general,” added Albuquerque, but we “will be following the process” closely and with caution.

    “We do not accept just the framework” if the rest of the agreement – including the SMTA – is not finalised, he explained, reiterating that nothing is agreed until everything is agreed.

    We insist, he added, the process be member driven, and that industry is only allowed to participate if civil society is included as well.

    As a part of the wider picture, both the United Kingdom and Switzerland suggested that Chan be given wider flexibility to decide on “phases” indicating the seriousness of a pandemic. Currently, WHO phases are based on geographical spread; but they should also look at severity, the countries said. Also, the UK said, WHO should look into broad-spectrum vaccines that are able to combat many strains of influenza and last a while. Then, the country said “we can talk about prevention rather than containment and mitigation.”

    Kaitlin Mara may be reached at kmara@ip-watch.ch.

     


    Leave a Reply

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website. By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

    By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

    2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

    3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

    4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

    5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

    6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

    7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

    8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

    9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.